Compare Nuwellis Inc (NUWE) vs D Wave Quantum Inc (QBTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs D Wave Quantum Inc — how do they compare? Nuwellis Inc trades at $0.69 (market cap $2.20M), while D Wave Quantum Inc trades at $14.82 (market cap $5.54B). The key difference: D Wave Quantum Inc is far larger — about 2518.2× Nuwellis Inc's market cap, and Nuwellis Inc is more actively traded (121,544 versus 16,671,452). Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 26 Days and D Wave Quantum Inc for 32 Days on average.
| NUWE | QBTS | |
|---|---|---|
Market Cap | $2.20M | $5.54B |
Volume | 121,544 | 16,671,452 |
Sector | Health | Technology |
52-Week High | $146.65 | $44.78 |
52-Week Low | $0.68 | $12.98 |
Typical Hold Time | 26 Days | 32 Days |
Enterprise Value | -$1.52M | $5.04B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
D-Wave Quantum Inc. (QBTS) trades at $15.22, down 3.61% on the day, reflecting a bearish technical trend. The company shows significant financial strain with a net income margin of -2001.59% and negative cash flow from operations. Despite this, all 13 covering analysts maintain a Buy rating with a consensus price target of $34.38, highlighting a stark divergence between current performance and long-term optimism.
The outlook is highly speculative. The potential reward is substantial if D-Wave achieves commercial success in quantum computing, but the risk is extreme due to persistent losses, high cash burn, and multiple ongoing securities fraud investigations, making it suitable only for risk-tolerant investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About D Wave Quantum Inc
D-Wave Quantum Inc. is a global leader in the development and delivery of quantum computing systems, software, and services. The company specializes in annealing quantum computers designed to solve complex optimization problems across industries such as logistics, materials science, and financial modeling. D-Wave offers its technology through the cloud, allowing customers to build and run real-world quantum applications today, making it a key player in the commercialization of quantum computing.
Read more on QBTS →
